ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,071.63
      0.02%
      US Tech 100
      16,903.60
      -0.92%
      Dow Jones
      38,460.92
      0.00%
      Brent Oil
      87.275
      0.06%
      Bitcoin
      63,763.83
      -0.80%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Mirum Pharmaceuticals Inc (MIRM)

      7. Mirum Pharmaceuticals Inc (MIRM) News

      MIRM Mirum Pharmaceuticals Inc

      24.02
      0.00 (0.00%)
      Pre Market
      Last Updated: 04:00:00
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Mirum Pharmaceuticals Inc MIRM NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.00 0.00% 24.02 04:00:00
      Open Price Low Price High Price Close Price Prev Close
      24.02
      more quote information »

      Recent News

      Date Time Source Heading
      4/10/202421:30BWMirum Pharmaceuticals Reports Inducement Grants Under Nasdaq..
      4/02/202408:30BWMirum Pharmaceuticals’ LIVMARLI (maralixibat oral solution)..
      3/25/202407:00GLOBESagimet Biosciences Announces Appointment of Tim Walbert and..
      3/13/202418:00BWMirum Pharmaceuticals’ LIVMARLI Receives FDA Approval for..
      3/08/202419:30BWMirum Pharmaceuticals Reports Inducement Grants Under Nasdaq..
      3/05/202408:00BWMirum Pharmaceuticals to Participate in Upcoming Investor..
      2/29/202408:30BWHepatology Publishes Six-Year Data Demonstrating Improved..
      2/28/202417:01EDGAR2Form NT 10-K - Notification of inability to timely file Form..
      2/28/202416:05EDGAR2Form 8-K - Current report
      2/28/202416:03BWMirum Pharmaceuticals Reports Fourth Quarter and Year-End..
      2/21/202416:05BWMirum Pharmaceuticals to Announce Fourth Quarter and..
      2/09/202421:15BWMirum Pharmaceuticals Reports Inducement Grants Under Nasdaq..
      2/05/202421:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/05/202421:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/02/202421:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/25/202419:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/25/202419:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/25/202419:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/19/202421:30BWMirum Pharmaceuticals Reports Inducement Grants Under Nasdaq..
      1/16/202416:15EDGAR2Form 8-K - Current report
      1/16/202408:30BWMirum Pharmaceuticals Appoints Joanne Quan, MD as Chief..
      1/10/202419:00BWMirum Pharmaceuticals Reports Inducement Grants Under Nasdaq..
      1/09/202420:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/09/202420:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/09/202420:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/08/202408:30EDGAR2Form 8-K - Current report
      1/08/202408:30BWMirum Pharmaceuticals Announces Preliminary Unaudited 2023..
      1/03/202408:45BWMirum Pharmaceuticals to Present at the 42nd Annual J.P...
      12/18/202316:06EDGAR2Form 8-K - Current report
      12/18/202308:30BWMirum Pharmaceuticals Announces Data from EMBARK Phase 2b..
      12/08/202319:30BWMirum Pharmaceuticals Reports Inducement Grants Under Nasdaq..
      12/06/202317:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/05/202300:00BWLIVMARLI (maralixibat) di Mirum Pharmaceutical è stato..
      11/20/202316:05BWMirum Pharmaceuticals to Present at the 2023 Evercore ISI..
      11/15/202320:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      11/15/202320:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      11/13/202314:00BWMirum Pharmaceuticals Presents New Data at The Liver..
      11/10/202317:30BWMirum Pharmaceuticals Reports Inducement Grants Under Nasdaq..
      11/03/202308:30BWMirum Pharmaceuticals to Present at the 2023 UBS Biopharma..
      11/02/202317:03EDGAR2Form S-8 - Securities to be offered to employees in employee..
      11/02/202316:59EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
      11/02/202316:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      11/02/202316:06EDGAR2Form 8-K - Current report
      11/02/202316:05EDGAR2Form 8-K/A - Current report: [Amend]
      11/02/202316:05BWMirum Pharmaceuticals Reports Third Quarter 2023 Financial..
      10/30/202308:30BWMirum Pharmaceuticals to Present New Data at The Liver..
      10/27/202308:45BWMirum Pharmaceuticals to Announce Third Quarter 2023..
      10/17/202316:39EDGAR2Form 8-K - Current report
      10/17/202316:30BWMirum Pharmaceuticals Announces New PDUFA Date for LIVMARLI..
      10/13/202316:47EDGAR2Form S-3ASR - Automatic shelf registration statement of..

      Your Recent History

      NASDAQ
      MIRM
      Mirum Pharmaceuticals
      Delayed Upgrade Clock